Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,439 | 13,476 | 23,368 | 18,520 | 29,688 |
| TOTAL | $15,104 | $14,683 | $23,700 | $18,924 | $31,404 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 820 | 820 | 0 | 0 | 0 |
| TOTAL | $820 | $820 | $N/A | $N/A | $N/A |
| Total Assets | $15,923 | $15,503 | $23,700 | $18,924 | $31,404 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,009 | 6,283 | 3,849 | 3,520 | 510 |
| Accrued Expenses | 3,068 | 7,359 | 12,925 | 6,143 | 1,835 |
| TOTAL | $7,276 | $14,602 | $17,175 | $9,962 | $2,345 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 89 | 807 | 567 | 373 |
| TOTAL | $N/A | $89 | $807 | $567 | $373 |
| Total Liabilities | $7,276 | $14,691 | $17,982 | $10,529 | $2,718 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,810 | 2,337 | 1,396 | 1,023 | 757 |
| Common Shares | 12 | 5 | 3 | 2 | 1 |
| Retained earnings | -184,138 | -164,273 | -134,354 | -95,093 | -66,832 |
| TOTAL | $8,648 | $813 | $5,719 | $8,394 | $28,687 |
| Total Liabilities And Equity | $15,923 | $15,503 | $23,700 | $18,924 | $31,404 |